Simulations Plus - Modeling & Simulation Software and Consulting Services for Pharmaceutical Research

Home

Products

Events

Resources

Support

Investors

Contact

	Advanced absorption, pharmacokinetic, and pharmacodynamic simulation software
	ADME-Tox property prediction and QSAR model-building
	Advanced data mining and molecule design
	Simulation of in vitro dissolution experiments FREE! Chemical structure drawing and ADMET property prediction

Simulations Plus Reports First Quarter FY2012 Financial Results

LANCASTER, CA, January 18, 2012 – Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical disc...

Simulations Plus Sets Date for 1st Quarter 2012 Earnings Release and Conference Call

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq:SLP), a leading provider of software and consulting services for pharmaceutical R&...

1st Qtr. Financial Results and Conference Call

You may view the 1st Qtr. 2012 financial results and conference call by clicking on Investors on the navigation bar above, then going to Conference Call. Windows Media Player is required.

New article written by our CEO

To read the invited "Perspective" article recently published in the Journal of Computer-Aided Molecular Design: "If we designed airplanes like we design drugs..." written by our CEO Walt Woltosz, please click here.

Another new article written by our Director of Life Sciences and Research Fellow
To read the invited "Perspective" article recently published in the Journal of Computer-Aided Molecular Design: "Lions and tigers and bears, oh my! Three barriers to progress in computer-aided molecular design", please click here.